Eastgate Biotech Corp.
ETBI
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -1.58M | -714.80K | -952.10K | -569.20K | -473.30K |
| Total Depreciation and Amortization | 73.70K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -117.40K | -110.60K | 656.50K | 77.20K | 3.80K |
| Change in Net Operating Assets | 295.50K | 694.40K | 174.10K | 323.20K | 829.00K |
| Cash from Operations | -1.33M | -131.00K | -121.50K | -168.90K | 359.40K |
| Capital Expenditure | -51.70K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -51.70K | -- | -- | -- | -- |
| Total Debt Issued | 1.47M | 38.10K | 142.00K | 128.50K | 104.00K |
| Total Debt Repaid | -85.30K | -59.50K | -- | -1.10K | -7.00K |
| Issuance of Common Stock | -- | 191.90K | -- | -- | -- |
| Repurchase of Common Stock | -71.90K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.31M | 170.50K | 142.00K | 127.40K | 97.00K |
| Foreign Exchange rate Adjustments | 0.00 | 29.80K | -11.10K | 41.50K | 4.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.70K | 69.20K | 9.30K | 0.00 | 460.60K |